Page last updated: 2024-10-16

4-hydroxybenzoic acid and Glioblastoma

4-hydroxybenzoic acid has been researched along with Glioblastoma in 1 studies

4-hydroxybenzoic acid : A monohydroxybenzoic acid that is benzoic acid carrying a hydroxy substituent at C-4 of the benzene ring.

Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belhadj, Z1
Ying, M1
Cao, X1
Hu, X1
Zhan, C1
Wei, X1
Gao, J1
Wang, X1
Yan, Z1
Lu, W1

Other Studies

1 other study available for 4-hydroxybenzoic acid and Glioblastoma

ArticleYear
Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Journal of controlled release : official journal of the Controlled Release Society, 2017, 06-10, Volume: 255

    Topics: Animals; Antibiotics, Antineoplastic; Brain Neoplasms; Cell Line; Cell Survival; Doxorubicin; Drug D

2017